Caissa Capital Management ltd. 4
4 · Avalo Therapeutics, Inc. · Filed Jun 27, 2023
Insider Transaction Report
Form 4
Caissa Capital Management ltd.
10% Owner
Transactions
- Purchase
Common Stock
2023-06-26$0.64/sh−1,425,700$917,153→ 0 total(indirect: See Footnote (1)) - Purchase
Common Stock
2023-06-26$0.62/sh−182,300$113,026→ 0 total
Footnotes (3)
- [F1]Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.45 to $0.84, inclusive.
- [F3]These shares are directly owned by Mr. Golestaneh in his personal capacity.